Relation of left ventricular lead placement in cardiac resynchronization therapy to left ventricular reverse

Aleksandr Rovner1, Lisa de las Fuentes, Mitchell N Faddis

  • 1Cardiovascular Imaging and Clinical Research Core Laboratory, St. Louis, Missouri, USA.

Insights

Optimal cardiac resynchronization therapy (CRT) involves lateral left ventricular (LV) lead placement. This position improves LV remodeling and diastolic dyssynchrony more effectively than other locations.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Cardiac Electrophysiology

Background:

  • Left ventricular (LV) lead placement in cardiac resynchronization therapy (CRT) impacts cardiac remodeling and dyssynchrony.
  • Optimal LV lead positioning for CRT is not well-defined.

Purpose of the Study:

  • To evaluate the effects of different LV lead placements on LV remodeling and dyssynchrony after CRT.
  • To compare the echocardiographic outcomes based on LV lead location (lateral, posterolateral, anterolateral).

Main Methods:

  • Echocardiography and Tissue Doppler imaging were used to assess LV volumes, ejection fraction, and systolic/diastolic dyssynchrony.
  • Sixty-one patients undergoing CRT were analyzed before and after the procedure.
  • Analysis of variance determined the impact of lead placement on echocardiographic variables.

Main Results:

  • Lateral LV lead placement was associated with significantly smaller LV volumes compared to posterolateral placement (p <0.01).
  • Improved diastolic dyssynchrony was observed with lateral lead placement versus anterior placement (p <0.05).
  • No significant differences in LV ejection fraction or systolic dyssynchrony improvement were found among groups.

Conclusions:

  • Lateral LV lead placement in CRT patients promotes greater reverse LV remodeling.
  • Lateral lead placement significantly improves diastolic dyssynchrony compared to other locations.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...